-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

652. Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 13, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Francesca Fazio1*, Alice Di Rocco1*, Tommaso Za, MD2*, Valeria Tomarchio, MD3*, Angela Rago, MD4*, Alfonso Piciocchi5*, Tommaso Caravita DI Toritto, MD, PhD4*, Ombretta Annibali, MD, PhD3*, Valerio De Stefano2*, Robin Foa, MD1, Maurizio Martelli, MD1* and Maria Teresa Petrucci, MD1

1Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
2Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy
3Unit of Hematology, Stem Cell Transplantation, University Campus Bio Medico, Rome, Italy
4UOSD Ematologia ASL Roma 1, Rome, Italy
5Italian Group For Adult Hematologic Diseases (GIMEMA), Roma, ITA

Cherng-Horng Wu, MD1*, Philip Tracy, MD1*, Denis Toskic, BS2* and Raymond Comenzo, MD3

1Department of Internal Medicine, Tufts Medical Center, Boston, MA
2John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
3Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA

Hee Jeong Cho1*, Juhyung Kim2*, Jung Min Lee2*, Dong Won Baek Sr., MD, PhD3*, Sung-Hoon Jung, MD4*, Sang Eun Yoon, MD5*, Sung-Soo Park, M.D. Ph.D.6*, Do Young Kim, MD7*, Ho-Jin Shin, MD, PhD8,9*, Yeung-Chul Mun, MD10*, Jun Ho Yi, MD11, Hyo Jung Kim, MD, PhD12*, Da Jung Kim13*, Ho Sup Lee, MD14, Sung Hwa Bae, MD15,16*, Sang Kyun Sohn, MD, PhD1,2,17*, Chang-Ki Min, M.D., Ph.D.6,18*, Kihyun Kim, MD, PhD19, Je-Jung Lee, MD, PhD20, Yoo Jin Lee21*, Jae-Cheol Jo21* and Joon Ho Moon22*

1Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
2Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
3Hematology&Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
4Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
5Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
6Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7Department of Hematology-oncology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea, Republic of (South)
8Busan National University Hospital, Busan, Korea, Republic of (South)
9Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
10Department of Hematology, Ewha Womans University, Seoul, Korea, Republic of (South)
11Department of Internal Medicine, Chung-ang University Hospital, Seoul, Korea, Republic of (South)
12Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea, Republic of (South)
13Kosin University Gosper Hospital, Pusan, Korea, Republic of (South)
14Division of Hematology-Oncology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea, Republic of (South)
15Department of Hematology/Oncology, Daegu Catholic Univ. Medical Center, Daegu, Korea, Republic of (South)
16Daegu Catholic niversity Medical Center, Daegu, Korea, Republic of (South)
17Department of Hematology–Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
18Seoul St. Mary's Hospital, Seoul, Korea, Republic of (South)
19Division of Hematology-Oncology, Department of Medicine,, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Seoul, Korea, Republic of (South)
20Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea, Republic of (South)
21Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Republic of (South)
22Kyungpook National University Hospital, Daegu, KOR

Zoe Craig, MSc1*, Christopher Parrish, MD2, Charlotte Pawlyn, BA, MB BChir, PhD, MRCP, FRCPath3, Martin F. Kaiser, MD, FRCP, FRCPath4, Catherine Olivier1*, John R Jones, MD5*, Mark T Drayson, MD6*, Roger G Owen, MD7*, Matthew W Jenner8*, Gordon Cook, MB ChB, PhD1*, Walter Martin Gregory, PhD1*, Faith E Davies, MD9, Gareth J. Morgan, MD, PhD10, Graham Jackson, MBBS, FRCP, FRCPath, MA, DM11 and David Cairns, PhD12*

1Leeds Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
2Leeds Teaching Hospitals NHS Trust, Leeds, ENG, United Kingdom
3Institute of Cancer Research, Sutton, United Kingdom
4The Institute of Cancer Research, London, United Kingdom
5Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom
6Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
7St. James's University Hospital, Leeds, United Kingdom
8Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
9Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas, New York, NY
10Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY
11Department of Haematology, NCCC Freeman Road Hospital, Newcastle Upon Tyne, United Kingdom
12Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

Joshua Richter, MD1, Jacob P. Laubach, MD2, Steve Stricker, PharmD, MS, BCOP, FISOPP, FHOPA3*, Fredrik H. Schjesvold, MD, PhD4, David Cohan, MD3*, Anna Sureda5, Ewa Lech-Marańda, MD, PhD6*, Meral Beksac, MD7, Vania Hungria8, Meletios A. Dimopoulos, MD9, Ajai Chari, MD10, Paul G. Richardson, MD11 and Philippe Moreau, MD, PhD12*

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, MA
3Secura Bio, Las Vegas, NV
4Oslo Myeloma Center/Department of Hematology, OSLO Univeristy Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
5Clinical Hematology Department, Institut Català d'Oncologia, Hospitalet, Hospital Duran i Reynals, Barcelona, Spain
6Institute of Hematology and Transfusion Medicine, Warsaw, Poland
7Cebeci Yerleskesi Dikimevi, Ankara, Turkey
8São Germano Clinic, São Paulo, Brazil
9Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
10Department of Hematology and Medical Oncology, Tisch Cancer Institute, Mt. Sinai School of Medicine, New York, NY
11Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
12University Hospital Hôtel-Dieu, Nantes, Nantes, France

Sarah Goldman-Mazur1*, Alissa Visram, MD2,3*, S Vincent Rajkumar, MD4*, Prashant Kapoor, MD3, Angela Dispenzieri, MD3, Martha Q. Lacy, MD5, Morie A. Gertz, M.D.3, Francis K. Buadi, MB, CHB6*, Suzanne R. Hayman, M.D.3, David Dingli, M.D., Ph.D.3, Taxiarchis Kourelis, M.D.3, Wilson I Gonsalves, MD3, Rahma M Warsame, MD3, Eli Muchtar, MD3, Nelson Leung, MD5, Robert A. Kyle, MD3 and Shaji K Kumar, MD7

1Division of Hematology, Mayo Clinic Rochester, ROCHESTER, MN
2Division of Hematology, Ottawa Hospital Research Institute, Ottawa, ON, Canada
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester
5Division of Hematology, Mayo Clinic Rochester, Rochester, MN
6Mayo Clinic Rochester, Division of Hematology, Rochester, MN
7Department of Hematology, Mayo Clinic Rochester, Rochester, MN

Sarah Goldman-Mazur, MD1*, Alissa Visram, MD2,3*, S Vincent Rajkumar, MD4*, Prashant Kapoor, MD3, Angela Dispenzieri, MD3, Martha Q. Lacy, MD1, Morie A. Gertz, M.D.3, Francis K. Buadi, MB, CHB5*, Suzanne R. Hayman, M.D.3, David Dingli, M.D., Ph.D.3, Taxiarchis Kourelis, M.D.3, Wilson I Gonsalves, MD3, Rahma M Warsame, MD3, Eli Muchtar, MD3*, Nelson Leung, MD1, Robert A. Kyle, MD3 and Shaji K Kumar, MD3

1Division of Hematology, Mayo Clinic Rochester, Rochester, MN
2Division of Hematology, Ottawa Hospital Research Institute, Ottawa, ON, Canada
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester
5Mayo Clinic Rochester, Division of Hematology, Rochester, MN

Charanpreet Singh, MD, MBBS1*, Sreejesh Sreedharanunni, MBBS, MD, DM2*, Vandana Panakkal3*, Aditya Jandial, MD, MBBS4*, Arihant Jain4*, Deepesh Lad, MD, DM4, Gaurav Prakash, MD, DM4*, Alka Khadwal, MD4* and Pankaj Malhotra, MD4

1Department of Internal Medicine, Chandigarh, India
2Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
3Postgraduate Institute of Medical Education and Research, Chandigarh, IND
4Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Cyril Quivoron, cyril.quivoron@gustaveroussy.fr1*, Helene Lecourt2*, Jean-Marie Michot3*, Julien Lazarovici, MD4*, Julien Rossignol, MD, PhD5*, David Ghez, MD, PhD6*, Veronique Vergé, MD7*, Veronique Saada8*, Alina Danu, MD9* and Vincent Ribrag, MD10

1Translational Research Hematological Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy Insitut, Villejuif, France
2Gustave Roussy, Villejuif, France
3Gustave Roussy Comprehensive Cancer Center, Villejuif, FRA
4Department d'Hématologie, Gustave Roussy Cancer Campus Grand Paris, Villejuif CEDEX, France
5Hematology, Gustave Roussy, Villejuif, France
6Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
7Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France
8Département de Biologie-Pathologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France
9Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
10DITEP-Hematology, Inserm U1170, Institut Gustave Roussy, Villejuif, France

Aurore Perrot1*, Cyrille Hulin2*, Margaret Macro3*, Laurent Frenzel, MD, PhD4, Carla Araujo, MD5*, Philippe Moreau, MD, PhD6*, Bruno Royer, MD7*, Karim Belhadj, MD8*, Denis Caillot, MD9*, Xavier Leleu, MD10,11, Anne Vekhoff, MD12*, Samantha Schulmann, MD13*, Salomon Manier, MD, PhD14, Lionel Karlin15*, Laure Vincent, MD16*, Sophie Rigaudeau, MD17*, Driss Chaoui18*, Ronan Garlantezec19*, Nathalie Texier20*, Marion Willaime21*, Catherine Boccaccio, MD22* and Olivier Decaux, MD, PhD23*

1CHU de Toulouse, IUCT-O, Université de Toulouse, Toulouse, France
2Department of Hematology, University Hospital Bordeaux, Bordeaux, France
3Hopital Cote De Nacre, Caen Cedex 9, FRA
4Assistance Publique–Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France
5Centre Hospitalier de la côte basque, Bayonne, France
6Hematology Department, University Hospital of Nantes, Nantes, France
7Hematology Department, St Louis Hospital,, Paris, FRA
8Centre Hospitalier et Universitaire Henri Mondor, Creteil, France
9Hematology Department, Dijon University Hospital, Dijon, France
10Department of Oncology-Haematology and Cell Therapy, CHU Poitiers, INSERM, Inserm CIC 1402, Poitiers, France
11Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France
12Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Paris, France
13Service d'Hématologie, CHRU Nancy, University Hospital, Nancy, France
14Service des Maladies du Sang, CHU Lille, Lille, France
15Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
16CHU de Montpellier / Département d'hématologie clinique, Hôpital Saint-Eloi, Montpellier, France
17Department of Clinical Hematology, Centre Hospitalier Versailles, Le Chesnay, France
18Department of Hematology, CH Argenteuil, Argenteuil, France
19CHU Rennes, Rennes, France
20kappa sante, PARIS, France
21kappa Santé, Papris, France
22IFM, paris, FRA
23Service d'Hématologie, CHU de Rennes, Rennes, France

Wenqiang Yan*, Huishou Fan*, Jingyu Xu*, Jiahui Liu*, Chenxing Du, MD*, Shuhui Deng, MD*, Weiwei Sui*, Yan Xu, MD*, Lugui Qiu and Gang An, MD, PhD*

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Olivier Decaux, MD, PhD1*, Aurore Perrot2*, Laurent Frenzel3*, Bruno Royer, MD4*, Carla Araujo, MD5*, Karim Belhadj, MD6*, Philippe Moreau, MD, PhD7*, Denis Caillot, MD8*, Xavier Leleu, MD9, Agathe Farge, MD10*, Anne Vekhoff, MD11*, Samantha Schulmann, MD12*, Jean Fontan, MD13*, Frederique Orsini14*, Laurence Sanhes, MD15*, Valentine Richez, MD16*, Arnaud Jaccard17*, Ronan Garlantezec18*, Nathalie Texier19*, Raphael Germain20*, Catherine Boccaccio, MD21* and Cyrille Hulin22,23*

1Service d'Hématologie, CHU de Rennes, Rennes, France
2CHU de Toulouse, IUCT-O, Université de Toulouse, Toulouse, France
3Department of Clinical Haematology, Hopital Necker-Enfants Malades, Paris, France
4Hematology Department, St Louis Hospital,, Paris, FRA
5Centre Hospitalier de la Cote Basque, Bayonne, France
6Centre Hospitalier et Universitaire Henri Mondor, Creteil, France
7Department of Hematology, Centre Hospitalier Universitaire-Nantes, Nantes, France
8Service d'Hématologie, CHU de Dijon, Dijon, France
9Hematology, Poitiers University Hospital / INSERM CIC 1402, Poitiers, France
10Service d'hématologie clinique, CHU Caen, Caen, France
11Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Paris, France
12Service d'Hématologie, CHRU Nancy, University Hospital, Nancy, France
13Jean Minjoz Hôpital, Besancon, France
14Service Hématologie, CH Annecy, ANNECY, France
15Department of Hematology, Saint Jean Hospital, Perpignan, France
16Hematology, University Nice Côte d'Azur, Nice, France
17CRIBL Lab, Centre Hospitalier Universitaire and Reference Center for AL Amyloidosis, Limoges, France
18CHU Rennes, Rennes, France
19kappa sante, PARIS, France
20kappa santé, paris, France
21IFM, paris, FRA
22Department of Hematology, University Hospital Bordeaux, Bordeaux, France
23Hôpital Haut Leveque, University Hospital, Pessac, France

Andrew Staron, MD1, Eric Burks, MD2* and Vaishali Sanchorawala, MD3

1Amyloidosis Center, Boston Medical Center, Boston, MA
2Department of Pathology, Boston University School of Medicine and Boston Medical Center, Boston
3Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA

Eloísa Riva, MD1*, Virginia Bove, MD2*, Jule Vasquez, MD3*, Camila Peña, MD4, Cristian Seehaus, MD5*, Cesar Samanez-Figari, MD6*, Justina Bustos, MD7, Marcos Hernandez, MD8*, Julio Fernandez, MD9*, Rosa Oliday Rios, MD10*, Yusaima Rodriguez, MD10*, Irving Figueredo, MD11* and Dorotea Fantl, MD12

1Hospital de Clínicas, Montevideo, Uruguay
2Hospital Central de las FF.AA., Montevideo, Uruguay
3Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
4Hematology Department, Hospital del Salvador, Santiago, Chile
5Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
6Oncosalud - AUNA, Lima, Peru
7Instituo Oncológico Nacional, Panama, Panama, Panama
8Universidad de Carabobo, Hospital Metropolitano del Norte, Carabobo, Venezuela (Bolivarian Republic of)
9Hospital General Universitario Dr. Gustavo Aldereguía Lima, Cienfuegos, Cuba
10Hospital Hermanos Ameijeiras, La Habana, Cuba
11Centro de Investigaciones Médico Quirúrgicas, La Habana, Cuba
12Hospital Italiano de Buenso Aires (HIBA), Buenos Aires, Argentina

Camille V Edwards, MD1, Hamza Hassan, MD1*, Grace Ferri2*, Karina Verma, MD1, Cenk Yildirim, MS3*, Nathanael R Fillmore, PhD3,4* and Nikhil C. Munshi, MD, PhD4,5

1Section of Hematology and Oncology, Boston Medical Center, Boston, MA
2Boston University School of Medicine, Boston, MA
3CSP Informatics Center, MAVERIC, VA Boston Healthcare System, Cambridge, MA
4Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA
5VA Boston Healthcare System, Boston, MA

Tao Xu1*, Stefka Tyanova1*, Mellissa Williamson2*, Alberto Rocci1*, Kasra Yousefi1* and Shaji K Kumar, MD3

1F. Hoffmann-La Roche Ltd, Basel, Switzerland
2Genentech, Inc., South San Francisco, CA
3Mayo Clinic, Rochester, MN

James B Smadbeck, PhD1*, Neeraj Sharma, PhD2*, Nadine Abdallah, MD3*, Hongwei Tang, PhD2*, Moritz Binder, MD3, Rafael Fonseca4, P. Leif Bergsagel, MD5, Jess F Peterson, MD2, Rhett P. Ketterling, MD2*, Patricia Greipp, DO2, S. Vincent Rajkumar, MD3*, Shaji K Kumar, MD3 and Linda B Baughn, PhD6

1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
5Division of Hematology, Mayo Clinic, Scottsdale, AZ
6Division of Laboratory Genetics, Mayo Clinic, Rochester, MN

Itai Zamir, MD student1*, Tamir Shragai, MD2,3*, Svetlana Trestman, MD4*, Tomer Ziv Baran, PhD5*, Efrat Luttwak, MD4*, Shai Levy6*, Irit Avivi, MD7,8* and Yael C Cohen, MD4,7

1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Gush Dan, Israel
3The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
5School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University., Tel-Aviv, Israel
6Tel Aviv Sourasky Medical Center, Tel Aviv, ISR
7The Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel Aviv, Israel, Tel Aviv, Israel
8Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Marcella Kaddoura, MD1, Moritz Binder, MD, MPH2*, David Dingli, M.D., Ph.D.2, Francis K. Buadi, MB, CHB3*, Martha Q. Lacy, MD4, Morie A. Gertz, M.D.2, Angela Dispenzieri, MD5, Prashant Kapoor, MD2, Yi L. Hwa, NP2, Amie Fonder, PA-C, MS2*, Miriam A. Hobbs, APRN, CNP, DNP2*, Suzanne R. Hayman, M.D.2, Nelson Leung, MD4, Ronald Go, MD2, Yi Lin5, Wilson I Gonsalves, MD2, Taxiarchis Kourelis, M.D.2, Rahma M Warsame, MD2, Robert A. Kyle, MD2, S. Vincent Rajkumar, MD2* and Shaji K Kumar, MD2

1Department of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Mayo Clinic Rochester, Division of Hematology, Rochester, MN
4Division of Hematology, Mayo Clinic Rochester, Rochester, MN
5Mayo Clinic, Rochester, MN

Marcella Kaddoura, MD1, Morie A. Gertz, M.D.2, David Dingli, M.D., Ph.D.2, Francis K. Buadi, MB, CHB3*, Martha Q. Lacy, MD4, Angela Dispenzieri, MD2, Prashant Kapoor, MD2, Suzanne R. Hayman, M.D.2, Wilson I Gonsalves, MD2, Taxiarchis Kourelis, M.D.2, Rahma M Warsame, MD2, Eapen K. Jacob, MD5 and Shaji K Kumar, MD2

1Department of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Mayo Clinic Rochester, Division of Hematology, Rochester, MN
4Division of Hematology, Mayo Clinic Rochester, Rochester, MN
5Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN

Adrian Alegre, MD, PhD1, Gonzalo Benzo Callejo, MD2*, Rafael Alonso Fernández, MD3*, Joaquin Martínez-López, MD, PhD4*, Ana Jimenez-Ubieto, MD, PhD5*, Clara Cuellar, MD6*, Elham Askari, MD7*, Elena Prieto, MD7*, Concha Alaez, MD8*, Beatriz Aguado, MD1*, Alberto Velasco, MD9*, Isabel Krsnik, MD, PhD10*, Laura Llorente, MD11*, Cristina Muñoz-Linares, MD12*, Ana Morales, MD13*, Eugenio Gimenez Mesa, MD14*, Rebeca Iglesias, MD15*, Carmen Martínez-Chamorro, MD16*, Arancha Alonso, MD17*, Carmen Jiménez-Montes18* and María Jesús Blanchard, MD19*

1Hospital Universitario de La Princesa, Madrid, Spain
2Hematology Deparment, Hospital Universitario La Princesa, Madrid, Spain
3Translational Hematology Group, Hospital 12 de Octubre-CNIO, Madrid, Spain
4Hospital Doce de Octubre, CIBERONC, Madrid, Spain
5Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
6Departament of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain
7Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
8Hospital Universitario Quirónsalud Madrid, Madrid, Spain
9Hospital Rey Juan Carlos, Móstoles, Spain
10Hospital Universitario Puerta de Hierro, Madrid, Spain
11Hematology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain
12Hematology department, Hospital Universitario del Henares, Madrid, Spain
13Hospital Universitario de Torrejón, Torrejón, Spain
14Hospital Infanta Sofía, San Sebastian De Los Reyes, ESP
15MD ANDERSON CANCER CENTER, MADRID, Spain
16Hospital Universitario Quirón Pozuelo, Madrid, ESP
17Hospital Universitario Quirón Salud, Madrid, Spain
18Hospital Universitario La Princesa, Madrid, Spain
19Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain

Eunice Lai1*, Yu Yang Soon2*, Ainsley Ryan Yan Bin Lee3*, Shi Yin Wong3*, Cinnie Yentia Soekojo, MD1, Melissa Ooi, MB Bch, BAO, MRCP(I), FRCPath, PhD1*, Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP1 and Sanjay De Mel, BSc, FRCPath, MRCP1*

1Department of Haematology Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore
2Department of Radiation Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore
3Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Hana Kim, MD1*, Darae Kim, MD, PhD2*, Jinoh Choi, MD, PhD3*, Eunseok Jeon, MD, PhD3*, Jung Eun Lee, MD, PhD4*, Ju Hong Min, MD, PhD5*, Joon Young Choi, MD, PhD6*, Jung-Sun Kim, MD, PhD7*, Seokjin Kim, MD, PhD8* and Kihyun Kim, MD, PhD9

1Division of Hematology-Oncology, Department of Medicine, Samsung medical center, Seoul, Korea, Republic of (South)
2Division of Cardiology, Department of Medicine, Samsung medical center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
3Division of Cardiology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
4Division of Nephrology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
5Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
6Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
7Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Seoul, Korea, Republic of (South)
8Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Seoul, KOR
9Division of Hematology-Oncology, Department of Medicine,, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Seoul, Korea, Republic of (South)

Emily I. Liu*, Nathan W. Sweeney, PhD and Jennifer M. Ahlstrom*

HealthTree Foundation, Lehi, UT

Agoston Gyula Szabo, MD1*, Jonathan Thorsen, MD, PhD2,3*, Katrine Fladeland Iversen, MD1*, Mette Bøegh Levring4*, Birgitte Preiss5*, Carsten Helleberg, MD6*, Marie Fredslund Breinholt, MD7*, Emil Hermansen, MD, PhD8*, Lise Mette Rahbek Gjerdrum, MD, PhD9*, Søren Bønløkke, MD10*, Katrine Nielsen11*, Eigil Kjeldsen11*, Manuela Teodorescu, MD12*, Marveh Dokhi13*, Eva Kurt14*, Casper Noergaard Strandholdt15*, Mette Klarskov Andersen, MD, DMSc16 and Annette J. Vangsted, MD17*

1Department of Hematology, Vejle Hospital, Vejle, Denmark
2University of Copenhagen, Copenhagen, Denmark
3COPSAC Copenhagen Prospective Studies on Asthma in Childhood, Copenhagen, Denmark
4Department of Hematology, Odense University Hospital, Odense, Denmark
5Odense University Hospital, Odense, DNK
6Department of Hematology, Herlev Hospital, Herlev, Denmark
7Dept. of Pathology, Copenhagen University Hospital Herlev, Herlev, Denmark
8Department of Hematology, Zealand University Hospital, Roskilde, Denmark
9Department of Pathology, Zealand University Hospital, Roskilde, Denmark
10Aarhus University Hospital, Aarhus N, DNK
11Aarhus University Hospital, Aarhus, DNK
12Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
13Rigshospitalet, Copenhagen, Denmark
14Regionshospitalet Holstebro, Holstebro, Denmark
15Department of Hematology, Hospital of South West Jutland, Esbjerg, DNK
16Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark
17Department of Hematology, Rigshospitalet, Copenhagen, Denmark

Ute Hegenbart, MD1*, Niklas Fuhr2*, Laura Huber2*, Christoph Kimmich3*, Kaya Veelken, MD4*, Tobias Dittrich, MD1*, Rita Ziehl2*, Fabian aus dem Siepen5*, Alexander Carpinteiro6*, Timon Hansen7*, Carsten Müller-Tidow, MD8*, Axel Benner, PhD9* and Stefan Schönland10*

1Amyloidosis Center, University of Heidelberg, Heidelberg, Germany
2Amyloidosis Center, University Hospital, Heidelberg, Germany
3Medizinische Klinik V and Amyloidosis Center, Universitätsklinikum Heidelberg, Heidelberg, Germany
4Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany
5Amyloidosis Center, Cardiology, University Hospital, Heidelberg, Germany
6University Hospital, Department of Hematology, Essen, Maine, DEU
7HOPA Praxis, Hamburg, Germany
8Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
9Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
10Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

Jeries Kort, MD1, Ravikumar Kyasaram2*, Shufen Cao3*, Pingfu Fu3*, James J. Driscoll, MD, PhD4 and Ehsan Malek, MD5

1University Hospitals Cleveland Medical Center, Cleveland, OH
2University hospitals cleveland medical center, cleveland, OH
3Case Western Reserve University, Cleveland, OH
4Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
5Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH

Rohan Medhekar, PhD1*, Tao Ran, PhD1*, Alex Z. Fu, PhD2,3*, Sharmila Patel, PhD1* and Shuchita Kaila, PhD1*

1Janssen Scientific Affairs, LLC, Horsham, PA
2Janssen Scientific Affairs, LLC, Titusville, NJ
3Georgetown University Medical Center, Washington, DC

Miao Jiang, PhD*, Lik Wee Lee, PhD*, Benjamin Eckert*, Audrey Demaree, PharmD and Tony Hewitt*

Adaptive Biotechnologies, Seattle, WA

Nicole Watts, PharmD, BCOP1*, Smith Giri, MD, MS2, Kelly N. Godby, MD3*, Gayathri Ravi, MD4, Luciano J. Costa, MD, PhD5 and Susan Bal, MD6

1Department of Pharmacy, University of Alabama at Birmingham Hospital, Birmingham, AL
2Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
3University of Alabama at Birmingham, Birmingham, AL
4O'Neal Cancer Center, University of Alabama Birmingham, Birmingham, AL
5University of Alabama at Birmingham, Vestavia, AL
6O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL

David Yashar, MD1,2*, Bernard Sean S. Regidor, BS1*, Scott Kristian Jew, BS1,3*, Sean Bujarski, BA1,3*, Marissa-Skye Goldwater, BS3*, Regina Swift1*, Gary Edward Schwartz1*, Shahrooz Eshaghian, MD4, Robert Vescio, MD5 and James R. Berenson, MD1,6,7

1Berenson Cancer Center, West Hollywood, CA
2Harbor-UCLA Medical Center, Torrance, CA
3Institute for Myeloma and Bone Cancer Research, West Hollywood, CA
4Compassionate Hematology & Oncology, Los Angeles, CA
5Department of Medicine, Division of Hematology and Cellular Therapy, Cedars-Sinai Medical Center, Los Angeles, CA
6Inst. for Myeloma & Bone Cancer Research, West Hollywood, CA
7Oncotherapeutics, West Hollywood, CA

Luciano J. Costa, MD, PhD1,2,3, Robert Frank Cornell, MD4*, Natalie S. Callander, MD5, Saurabh Chhabra, MD, MS6, Michaela Liedtke, MD7, Ankit Kansagra, MD8, Kelly N. Godby, MD2*, Susan Bal, MD9, Smith Giri, MD, MS10, Ehsan Malek, MD11,12, Yubin Kang, MD13, Ravi Vij, MBBS14,15, Saad Z. Usmani, MD MBA FACP16, Parameswaran Hari17 and Shaji K Kumar, MD18

1University of Alabama at Birmingham, Vestavia, AL
2University of Alabama at Birmingham, Birmingham, AL
3Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
4Vanderbilt University, Nashville, TN
5University of Wisconsin, Madison, WI
6MUSC, Milwaukee, WI
7Division of Hematology, Department of Medicine, Stanford University, Stanford, CA
8Blood and Marrow Transplant Program, University of Texas Southwestern Medical Center, Dallas, TX
9O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
10Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
11Adult Hematologic Malignancies & Stem Cell Transplant Section, Case Western Reserve Universtity, Shaker Hts, OH
12Division of Hematology and Oncology, Case Western Reserve University, Cleveland, OH
13Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
14Washington University School of Medicine, Ballwin, MO
15Washington University School of Medicine, St. Louis, MO
16Levine Cancer Institute, New York, NY
17Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
18Department of Hematology, Mayo Clinic Rochester, Rochester, MN

James E Hoffman, MD1, Marla B. Sultan, MD2*, Balarama Gundapaneni, MS3* and Ronald Witteles, MD4*

1University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
2Pfizer, New York, NY
3Pfizer, Groton, CT
4Stanford Amyloid Center, Stanford University School of Medicine, Stanford, CA

Susanne Ghandili1*, Martin Schönlein2*, Heiko Becher, MD3*, Christian Wiessner4*, Marc Lütgehetmann, MD5*, Julian Schulze zur Wiesch, MD6*, Carsten Bokemeyer7*, Marianne Sinn, MD2*, Lisa Leypoldt, MD8* and Katja Weisel, MD9

1Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Georgia, Germany
2Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
32Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg Eppendorf, Hamburg, Germany
6Department of Medicine, Section Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
7Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Hospital Eppendorf, Hamburg, Germany
8Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, DEU
9II. Department of Medicine, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Ben A Derman, MD1, Andrew J. Belli2*, Ching-Kun Wang, MD3*, Eric Hansen, MS3*, Spencer S Langerman, BS4*, Andrzej Jakubowiak5 and Brian C-H Chiu, PhD4

1Section of Hematology/Oncology, University of Chicago, Chicago, IL
2COTA, Inc., New York, NY
3COTA, Inc., Boston, MA
4Department of Public Health Sciences, University of Chicago, Chicago, IL
5University of Chicago, Chicago, IL

Florentin Späth, MD1*, Widad Tahiru2*, Antonio Izarra, MD2*, Johan Hultdin, MD PhD3* and Wendy Yi-Ying Wu, PhD2*

1Department of Radiation Sciences, Oncology, Umea University, Umeå, Sweden
2Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
3Department of Medical Biosciences, Clinical Chemistry, Umea University, Umea, Sweden

Evangelos Terpos, MD, PhD1, Maria Gavriatopoulou, MD1*, Ioannis Ntanasis-Stathopoulos, MD, MSc, PhD1*, Alexandros Briasoulis, MD, PhD1*, Sentiljana Gumeni, PhD2*, Panagiotis Malandrakis, MD1*, Despina Fotiou, MD, PhD1*, Eleni-Dimitra Papanagnou, PhD2*, Magdalini Migkou, MD, PhD1*, Foteini Theodorakakou, MD1*, Maria Roussou, MD1*, Evangelos Eleutherakis-Papaiakovou, MD, MSc, PhD1*, Nikolaos Kanellias, MD1*, Ioannis P. Trougakos, PhD2*, Efstathios Kastritis, MD3* and Meletios-Athanasios Dimopoulos, MD, PhD1

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Department of Cell Biology and Biophysics, National and Kapodistrian University of Athens, Faculty of Biology, Athens, Greece
3Department of Clinical Therapeutics, National and Kapodistrian University of Athens, ATHENS, Greece

Elias K Mai, MD1*, Thomas Hielscher2*, Uta Bertsch, MD1,3*, Hans Salwender, MD4*, Sonja Zweegman5, Markus Munder6*, Lucia Pantani, MD, PhD7*, Peter Brossart, MD8, Meral Beksac, MD9, Igor Wolfgang Blau, MD10*, Marc-Steffen Raab1*, Jan Dürig, MD11*, Nicola Giesen, MD1*, Britta Besemer12*, Roland Fenk, MD13*, Peter Reimer, MD14*, Bronno van der Holt, PhD15*, Mathias Haenel16*, Ivana v. Metzler, MD17*, Ullrich Graeven18*, Mario Boccadoro19, Christof Scheid20, Meletios A. Dimopoulos, MD21, Katja Weisel22*, Michele Cavo, MD, PhD7*, Pieter Sonneveld23 and Hartmut Goldschmidt3,24

1Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
2Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
3National Center for Tumor Diseases Heidelberg, Heidelberg, Germany
4Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany
5Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
6Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
7Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
8Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany
9Department of Hematology, Ankara University School of Medicine, Ankara, Turkey
10Dept. Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Berlin, Germany
11Department of Hematology, Essen University Hospital, Essen, Germany
12Department of Hematology, Oncology, and Immunology, University of Tuebingen, Tuebingen, Germany
13Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Duesseldorf, Germany
14Hematology, Oncology and Stem Cell Transplantation, Evangelisches Krankenhaus Essen-Werden gGmbH, Essen, Germany
15HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
16Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
17Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany
18Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Moenchengladbach, Germany
19Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
20Department of Internal Medicine I, University of Cologne, Cologne, Germany
21Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
22Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
23Erasmus MC University and Medical Center, Rotterdam, Netherlands
24University Hospital Heidelberg and National Center of Tumor Diseases, Heidelberg, Germany

Sundar Jagannath, MD1*, Thierry Facon, MD2*, Ashraf Z. Badros, MD3, Moshe Levy, MD4*, Philippe Moreau, MD, PhD5*, Sosana Delimpasi, MD6*, Maryana Simonova, MD7*, Ivan Spicka, MD, Prof, PhD8*, Iryna Kriachok9*, Maria Gavriatopoulou, MD10*, Halyna Pylypenko, MD11*, Holger W Auner, MD, PhD12, Xavier Leleu, MD13, Vadim Doronin, MD, PhD14*, Ganna Usenko, MD15*, Roman Hajek, MD, PhD16, Reuben Benjamin, MD17, Tuphan Kanti Dolai, MBBS, MD, DNB, DM18*, Dinesh Kumar Sinha, MD19*, Chris P. Venner20, Mamta Garg, MD, FRCP, FRCPath21*, Mercedes Gironella Mesa, MD22*, Artur Jurczyszyn, MD23*, Tadeusz Robak, MD, PhD24, Monica Galli, MD25*, Craig Thomas Wallington-Beddoe, BSc, MBBS, MBiostat, PhD, FRACP, FRCPA26*, Atanas Radinoff, MD27*, Galina Salogub, MD, PhD28*, Don Stevens, MD29, Supratik Basu30*, Anna Marina Liberati, MD31, Hang Quach, FRACP, FRCPA32, Veselina S Goranova Marinova, MD, PhD33, Jelena Sreten Bila, MD, PhD34*, Eirini Katodritou, MD35*, Andrew DeCastro, PhD36*, Yi Chai, PhD37*, Dane R. Van Domelen, PhD36*, Moran Mishal, MD37*, Ohad S. Bentur, MD MHA36*, Jatin Shah, MD37, Sharon Shacham, PhD, MBA36*, Michael G. Kauffman, MD, PhD36, Sebastian Grosicki, MD, PhD38 and Paul G. Richardson, MD39

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2University Hospital, Lille, France
3University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
4Baylor University Medical Center, Dallas, TX
5University of Nantes, Nantes, France
6General Hospital Evangelismos, Athens, Greece
7Institute of Blood Pathology & Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, MA, Ukraine
8Vseobecna Fakultni Nemocnice V Praze, I. Interni Klinika, Klinika Hematologie, Praha 2, Prague, Czech Republic
9National Cancer Institute, Kiev, Ukraine
10Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens,, Athens, Greece
11Department of Hematology, Cherkassy Regional Oncology Center, Cherkassy, Ukraine
12Imperial College Healthcare NHS Trust, London, United Kingdom
13Department of Oncology-Haematology and Cell Therapy, CHU Poitiers, INSERM, Inserm CIC 1402, Poitiers, France
14City Clinical Hospital #40, St. Petersburg, Russian Federation
15City Hematology Center, City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine
16Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
17Department of Haematology, Kings College Hospital NHS Foundation Trust, London, CA, United Kingdom
18Haematology, Nil Ratan Sircar Medical College and Hospital, Kolkata, India
19State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India
20University of Alberta, Edmonton, Canada
21Leicester Royal Infirmary, Leicester, United Kingdom
22Haematology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain
23Plasma Cell Dyscrasia Center, Jagiellonian University Department of Hematology, Faculty of Medicine,, Kraków, Poland
24Medical University of Lodz, Lodz, Poland
25Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy
26Flinders Medical Centre Flinders University, Adelaide, Australia
27University Multiprofile Hospital for Active Treatment, Sofia, Bulgaria
28Almazov National Medical Research Centre, St. Petersburg, Russian Federation
29Norton Healthcare, Norton Cancer Institute, Louisville, KY
30The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom
31Department of Onco-Hematology, University of Perugia, Santa Maria Hospital, Terni, Italy
32University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
33Clinic of Hematology, University Multiprofile Hospital for Active Treatment "Sv. Georgi", EAD, Plovdiv, Medical University of Plovdiv, Plovdiv, Bulgaria
34Clinic for Hematology, Clinical Center of Serbia, University of Belgrade, Belgrade, SRB
35Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
36Karyopharm Therapeutics Inc., Newton, MA
37Karyopharm Therapeutics, Newton, MA
38Medical University of Silesia, Katowice, Poland
39Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Ryan Stevenson1, Diane M. Carpenter, MPH2*, Adnan Khan, MD3*, Raleigh Fatoki, MD, MBA3*, Sumanth Rajagopal, MD4*, Michael M Green, MD5*, Bijay Nair, MD, MPH6* and David M. Baer, MD5

1Department of Hematology/Oncology, Kaiser Permanente, South Sacramento, CA
2Division of Research, Kaiser Permanente, Oakland, CA
3Department of Internal Medicine, Kaiser Permanente, Oakland, CA
4Department of Infectious Diseases, Kaiser Permanente, Oakland, CA
5Department of Hematology/Oncology, Kaiser Permanente, Oakland, CA
6Department of Hematology/Oncology, Kaiser Permanente, Roseville, CA

Ayelet I Rubenstein1*, Sheila K Pierson, MSc2* and David C Fajgenbaum, MD, MBA, MSc3

1Center for Cytokine Storm & Treatment Laboratory, Department of Medicine, University of Pennsylvania, Philadelphia, PA
2Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
3Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Jordan Nunnelee, BA1*, Muhammad Salman Faisal, MD2, Qiuhong Zhao, MS3*, Francesca Cottini, MD4, Patrick Elder, MS3*, Ashley E. Rosko, MD3, Maria Chaudhry, MBBS3, Abdullah Khan, MBBS, MSc3, Srinivas Devarakonda, MD3, Naresh Bumma, MD3, Don M Benson Jr., MD5, Yvonne A. Efebera, MD, MPH6 and Nidhi Sharma, PhD7*

1The Ohio State University College of Medicine, Columbus, OH
2Hematology and Stem Cell Transplant, James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
5Riney Family Myeloma Center for Research Excellence, Ohio State University Medical Center, Columbus, OH
6OhioHealth Physician Group, Columbus, OH
7Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Toshiki Terao, MD1*, Youichi Machida, MD2*, Ukihide Tateishi, M.D, PhD3*, Takafumi Tsushima, MD4*, Kentaro Narita, MD5*, Daisuke Ikeda, MD6*, Ami Fukumoto, MD7*, Ayumi Kuzume, MD8*, Rikako Tabata, MD8*, Daisuke Miura, MD9*, Masami Takeuchi, MD4* and Kosei Matsue, MD, PhD10

1Division of Hematology/Oncology,, Kameda Medical Center, Kamogawa, JPN
2Department of Radiology, Kameda Medical Center, Kamogawa, Japan
3Department of Diagnostic Radiology, Tokyo Medical and Dental University, Tokyo, Japan
4Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan
5Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, JPN
6KAMEDA MEDICAL CENTER, Chiba, Japan
7Kameda Medical Center, Kamogawashi, Japan
8Division of Hematology/Oncology, Kameda Medical Centor, Kamogawa, Japan
9Division of Hematology/Oncology, Kameda Mecial Center, Kamogawa, JPN
10Division of Hematology/Oncology, Kameda General Hospital, Kamogawa, Japan

Toshiki Terao, MD1*, Takafumi Tsushima, MD2*, Daisuke Miura, MD3*, Daisuke Ikeda4*, Ami Fukumoto, MD4*, Ayumi Kuzume, MD5*, Rikako Tabata, MD5*, Kentaro Narita, MD6*, Masami Takeuchi, MD2* and Kosei Matsue, MD, PhD7

1Division of Hematology/Oncology,, Kameda Medical Center, Kamogawa, JPN
2Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan
3Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan
4Kameda Medical Center, Kamogawashi, Japan
5Division of Hematology/Oncology, Kameda Medical Centor, Kamogawa, Japan
6Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, CHI, Japan
7Division of Hematology/Oncology, Kameda General Hospital, Kamogawa, Japan

Efstathios Kastritis, MD1*, Evangelos Terpos, MD, PhD1, Aimilia D. Sklirou, PhD2*, Foteini Theodorakakou, MD1*, Despina Fotiou, MD, PhD1*, Eleni-Dimitra Papanagnou, PhD2*, Tina Bagratuni, PhD1*, Nikolaos Kanellias, MD1*, Magdalini Migkou, MD, PhD1*, Ioannis Ntanasis-Stathopoulos, MD, MSc, PhD1*, Panagiotis Malandrakis, MD1*, Ioanna Charitaki1*, Maria Gavriatopoulou, MD1*, Ioannis P. Trougakos, PhD2* and Meletios-Athanasios Dimopoulos, MD, PhD1

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Department of Cell Biology and Biophysics, National and Kapodistrian University of Athens, Faculty of Biology, Athens, Greece

Matteo Claudio Da Via1,2*, Marta Lionetti, PhD1,2*, Antonio Matera1,2*, Erica Travaglino3*, Ugo Lucca4*, Emma Riva4*, Mauro Tettamanti4*, Luca Baldini, MD, PhD1,2*, Antonino Neri, MD1,2, Matteo G. Della Porta, MD3* and Niccolo Bolli, MD PHD1,5

1Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
2BMT Center - Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
3Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano (Milan), Italy
4Department of Neuroscience, Laboratory of Geriatric Neuropsychiatry, IRCCS Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy
5Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Andrew R. Branagan, MD, PhD1, Matthew M Lei, PharmD, BCOP2*, Jenny S Maron, BS3*, Andrew J Yee, MD4*, Elizabeth O’Donnell, MD1*, Jorge J. Castillo, MD5, Noopur S. Raje, MD4, Steven P Treon, MD, PhD, FRCP5, Catherine A Flynn, NP5*, Clifton C. Mo, MD6, Omar Nadeem, MD6, Paul G. Richardson, MD6, Cristina Panaroni, PhD7, Kirsten Meid, MPH5*, Zachary S. Bernstein4*, Rebecca T. Lyons4*, Zachary R Hunter, PhD5, Maria Luisa Guerrera, MD5*, Marilyn T. Gammon, RN4*, Kathleen J. Lively, RN4*, Lisette Packer, RN4*, Matthew Waterman4*, Raquel Gallagher4*, Boris Juleg, MD, PhD3*, Galit Alter, PhD3* and Shayna Sarosiek, MD5

1Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
2Pharmacy Department, Massachusetts General Hospital, Boston, MA
3Ragon Institute at Harvard University, Cambridge
4Massachusetts General Hospital Cancer Center, Boston, MA
5Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7Center for Multiple Myeloma, Massachusetts General Hospital - Cancer Center, Boston, MA

Maria Gavriatopoulou, MD1*, Evangelos Terpos, MD, PhD1, Panagiotis Malandrakis, MD1*, Ioannis Ntanasis-Stathopoulos, MD, MSc, PhD1*, Alexandros Briasoulis, MD, PhD1*, Sentiljana Gumeni, PhD2*, Despina Fotiou, MD, PhD1*, Eleni-Dimitra Papanagnou, PhD2*, Magdalini Migkou, MD, PhD1*, Foteini Theodorakakou, MD1*, Evangelos Eleutherakis-Papaiakovou, MD, MSc, PhD1*, Nikolaos Kanellias, MD1*, Ioannis P. Trougakos, PhD2*, Efstathios Kastritis, MD, PhD1* and Meletios-Athanasios Dimopoulos, MD, PhD1

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Department of Cell Biology and Biophysics, National and Kapodistrian University of Athens, Faculty of Biology, Athens, Greece

Sudeep Karve1*, Shaji K Kumar, MD2, Veronica Gonzalez De La Calle, MD, PhD3*, Silvia Mangiacavalli, MD4*, Chang-Ki Min, M.D., Ph.D.5*, Efstathios Kastritis, MD6*, Graca Esteves, MD7*, Michel Delforge8, Fernando Escalante, MD9*, Jin Lu, MD10, Yang Liu, PhD11*, Max Bittrich, MD12, Charalampia Kyriakou, MD, PhD13, Andrew J. Yee, MD14, Emma Arriola, PhD15, Jeremy A. Ross, PhD16*, Shivaji Manthena, MS17* and Brian G.M. Durie, MD18

1Abbvie Inc., North Chicago, IL
2Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Departamento de Hematología, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
4Division of Hematology, IRCCS Fondazione Policlinico San Matteo Pavia, Pavia, Italy
5Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
6Department of Clinical Therapeutics, National and Kapodistrian University of Athens, ATHENS, Greece
7Department of Hematology and Marrow Transplantation, Hospital de Santa Maria - Centro Hospitalar Lisboa Norte, Lisbon, Portugal
8Department of Hematology, University Hospitals Leuven, Leuven, Belgium
9Department of Hematology, Hospital Universitario de Leon, Leon, Spain
10Peking University People’s Hospital, National Clinical Research Center for Hematologic Disease, Collaborative Innovation Center of Hematology, Beijing, China
11Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China, Beijing, China
12Universitätsklinikum Würzburg, Wuerzburg, DEU
13University College London Hospital, UCLH Centre for Waldenström and Related Conditions, London, United Kingdom
14Massachusetts General Hospital Cancer Center, Boston, MA
15Abbvie, Maidenhead, GBR
16AbbVie Inc., North Chicago, IL
17AbbVie, Inc, Mettawa, IL
18Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA

Al-Ola Abdallah, MD1, Zahra Mahmoudjafari, PhD2*, Meera Mohan, MD, MS3*, Joseph P. McGuirk, DO4, Cassie Remker, RN, BSN5*, Margaret Foss, ANP5*, Ellie Karloff, RN, BSN5*, Heather Fitch, RN, BSN5*, Ghulam Rehman Mohyuddin, MD6 and Shebli Atrash, MD7

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
3Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
4Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwoon, KS
5University of Kansas Medical Center, Westwood, KS
6University of Utah, Salt Lake City, UT
7Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC

Nadine Abdallah, MD1*, Eli Muchtar, MD1, Angela Dispenzieri, MD2, Morie A. Gertz, M.D.1, Prashant Kapoor, MD1, Martha Q. Lacy, MD3, Suzanne R. Hayman, M.D.1, Francis K. Buadi, MB, CHB4*, Wilson I Gonsalves, MD1, Nelson Leung, MD3, David Dingli, M.D., Ph.D.1, Taxiarchis Kourelis, M.D.1, Rahma M Warsame, MD1, Moritz Binder, MD, MPH1*, Robert A. Kyle, MD1, S. Vincent Rajkumar, MD1* and Shaji K Kumar, MD2

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic Rochester, Rochester, MN
4Mayo Clinic Rochester, Division of Hematology, Rochester, MN

Jiasheng Wang, MD1, Raul Arroyo-Suarez, MD2* and William Tse, MD3

1University Hospitals Cleveland Medical Center, Cleveland, OH
2Department of Medicine, MetroHealth Medical Center, Cleveland, OH
3Department of Hematology and Oncology, The MetroHealth System campus of Case Western Reserve University, Cleveland, OH

*signifies non-member of ASH